ArticleJournal of cancer research and clinical oncology2016

Young age and high cost are associated with future preference for stopping tyrosine kinase inhibitor therapy in Chinese with chronic myeloid leukemia.

Qian Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.